ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 80 filers reported holding ENZON PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $343,000 | +6.2% | 314,907 | +5.4% | 0.00% | – |
| Q3 2014 | $323,000 | +9.5% | 298,812 | +5.3% | 0.00% | – |
| Q2 2014 | $295,000 | +1.0% | 283,830 | +0.0% | 0.00% | – |
| Q1 2014 | $292,000 | +156.1% | 283,828 | +188.8% | 0.00% | – |
| Q4 2013 | $114,000 | -70.2% | 98,271 | -56.8% | 0.00% | – |
| Q3 2013 | $382,000 | -49.5% | 227,591 | -39.8% | 0.00% | – |
| Q2 2013 | $756,000 | – | 377,861 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ativo Capital Management LLC | 416,564 | $575,000 | 0.20% |
| ALGERT GLOBAL LLC | 124,891 | $150,000 | 0.08% |
| Rotella Capital Management, Inc. | 64,910 | $78,000 | 0.06% |
| Spark Investment Management LLC | 362,800 | $431,000 | 0.06% |
| Icahn Capital | 5,904,863 | $7,086,000 | 0.02% |
| GLOBEFLEX CAPITAL L P | 99,954 | $120,000 | 0.02% |
| Kovack Advisors, Inc. | 16,050 | $19,000 | 0.01% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 110,202 | $132,000 | 0.01% |
| Renaissance Technologies | 3,614,909 | $4,338,000 | 0.01% |
| CSS LLC/IL | 158,829 | $191,000 | 0.01% |